image 2 image 4
Skip Navigation Links
 Home 
 Congress Structure 
 Important Dates 
 Venue 
 Registration 
 Pre Registered 
 Abstracts 
 Scientific Program 
 Exhibition 
 Contact Us 
 Personal page 
 Photo and Film Festival 
       XXVII Annual Congress of the Iranian Society of Ophthalmology        بـیــست و هفتمین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
مقاله Abstract


Title: Retinopathy of prematurity (ROP): A 7-year review of treated premature infants.
Author(s): Shokufeh Tavassoli, Richard Wach, Richard Haynes, Richard Markham, Cathy Williams
Presentation Type: Oral
Subject: Posterior Segment
Others:
Presenting Author:
Name: Shokufeh Tavassoli
Affiliation :(optional) Bristol Eye Hospital
E mail: shokufeh_tavassoli@hotmail.com
Phone:
Mobile: 44 07827327298
Purpose:

Retinopathy of prematurity (ROP) is a potentially blinding disorder affecting premature infants. We hypothesised that the increased survival of very premature babies may be affecting the overall numbers requiring treatment. The aims of this study were to identify the annual rate of ROP treatment during the period 2009-2015 and to consider the incidence of ROP treatment by gestational age at birth.

Methods:

All infants treated for ROP by the Vitreoretinal team at Bristol Eye Hospital (included the two level 3 neonatal units, St Michaels and Southmead Hospitals) during the period 2009-2015 had their clinical data retrospectively reviewed.

Results:

A total of 95 infants were treated for ROP during this period (48 male, 47 female, 699.9±160.7g mean±SD birth weight). Treatments for ROP consisted of, one course of laser alone (82/95), two courses of laser (5/95), laser and an anti-VEGF intravitreal injection (7/95), and laser with vitrectomy (1/95). The mean age of treatment was at 90.6±45.7 days (mean±SD). A higher percentage of premature infants were treated for ROP in 2015 compared to 2009. The results showed that the number of those born under 27 weeks gestation that survived to complete ROP screening to have increased over time. The incidence of ROP treatment for those born at 23 weeks gestation was 55%, which was markedly higher than for those born at 26 weeks gestation, where it was 12%.

Conclusion:

In conclusion the increase in ROP treatment seen in recent years in this unit may be due to the increased survival of extremely premature babies.

Attachment:





Skip Navigation Links
        صفحه اصلی
        ساختار کنگره
        تاریخ های مهم
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
        اطلاعات هتل - رزرو
        مقالات
        برنامه کنگره
        جشنواره فیلم و عکس
        نمایشگاه
        تماس با ما
        صفحه شخصی
        جستجوی سخنران
        آرشیو کنگره سالهای گذشته
        شب کنگره چشم پزشکی
 
ورود شرکت کنندگان
نام کاربری :
کلمه عبور :
  کلمه عبور خود را فراموش کرده ام.
Total Visits
Find us on Social Media
Congress Count Down
Today Label
Last Month Label
Total Visitors Label